Comparison Chart Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
NYSE
01:30:00 29/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.500 USD | -0.79% |
|
-15.82% | -9.09% |
| 21/09 | Perspective Therapeutics, Inc.(NYSEAM:CATX) dropped from S&P Biotechnology Select Industry Index | CI |
| 18/09 | William Blair Initiates Perspective Therapeutics With Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -0.79% | -15.82% | -9.09% | -26.47% | -60.75% | 29Cr |  | |  |
- Stock Market
- Stocks
- CATX Stock
- Charts Perspective Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
